EDITORIAL SECTION

Articles

The Competitive Generic Therapy (CGT)

Generic medications are critical in the healthcare sector due to their affordability and accessibility to the public while maintaining comparable quality efficacy and safety to that of branded products Generic medications research and development followed by commercialisation also fosters competition and innovation within the pharmaceutical

Harnessing the Potential of mRNA Technology for Precision Cancer Treatment

Recent developments in medical research have highlighted the potential of mRNA as a viable approach for addressing challenges in healthcare particularly in combating infectious diseases and cancer

Quality by Design Is a Mindset, Not a Milestone

Every medicine is a promise about consistency The tablet dispensed in Milan next spring must behave exactly like the one tested in a trial four years earlier and like the ten million made between them

Building Resilient Pharma Supply Chains to Strengthen Patient Care

The failure to deliver a temperaturesensitive biologic or a critical maintenance drug on time is becoming a patient outcome crisis not just an operational inefficiency By fortifying our global logistics networks we proactively safeguard the availability of lifesaving therapies and essential healthcare supplies securing the healthcare industrys central promise to global health This strategic impera...

Biopharma M&A and Licensing: Strategic Partnerships Fueling Innovation

For much of the last decade acquisitions and licensing agreements were debated in European boardrooms as rival answers to the same question how to refill a pipeline faster than internal research alone allows That framing no longer holds In the most effective pharmaceutical companies run both instruments in parallel choosing between them asset by asset according to scientific maturity geographic o...

What Are the Benefits of Implementing a Modern MES in Pharma?

The pharmaceutical sector is rapidly changing in a bid to match the increasing pressure of regulation attain perfection in product quality and hasten the timetomarket A Pharma MES or Manufacturing Execution System is one of the most strategic investments that are strategically placed in this environment in terms of operational excellence

Techno Trends

UGA researchers develop oral drug candidate targeting drug-resistant malaria

Researchers from the University of Georgia UGA and the University of Illinois Chicago have developed a new oral antimalarial drug candidate that could help address drugresistant malaria

Projects

Evonik Launches US$94 Million (EUR 80 million) Biotechnology Expansion in Slovakia

Evonik has commenced construction of a new biotechnology expansion at its Fermas facility in Slovensk upa Slovakia The development is part of an approximately US million investment EUR million

Research Insights

One-month physicochemical stability study of idarubicin prepared in polyolefin-type bags for the treatment of hematological diseases

Idarubicine is a mainstay of the treatment strategy for hematological cancer The literature lacks stability data that comply with current preparation practices and recommendations for conducting stability studies

whitepaper

Post-Translational Modifications in Drug Discovery: From Molecular Regulation to Clinical Impact

For decades the central dogma of molecular biology has anchored our understanding of cellular function DNA to RNA to protein But this linear view is incomplete A growing body of evidence shows that much of biologys